Variant report

Variant	nsv947555
Chromosome Location	chr1:184857808-184861749
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr1:184861328-184861635	GM12878	blood:	n/a	chr1:184861574-184861584
2	BATF	chr1:184861020-184861604	GM12878	blood:	n/a	chr1:184861574-184861584
3	CEBPB	chr1:184857700-184858072	Hela-S3	cervix:	n/a	n/a
4	CTCF	chr1:184858335-184858395	K562	blood:	n/a	n/a
5	CTCF	chr1:184859840-184859990	GM12873	blood:	n/a	n/a
6	CTCF	chr1:184861580-184861730	K562	blood:	n/a	n/a
7	CUX1	chr1:184857615-184857906	K562	blood:	n/a	n/a
8	EBF1	chr1:184861179-184861401	GM12878	blood:	n/a	n/a
9	EBF1	chr1:184859730-184859898	GM12878	blood:	n/a	n/a
10	EP300	chr1:184858993-184859404	SK-N-SH_RA	brain:	n/a	n/a
11	EP300	chr1:184857576-184858245	SK-N-SH_RA	brain:	n/a	n/a
12	EP300	chr1:184857435-184858200	SK-N-SH	brain:	n/a	n/a
13	EP300	chr1:184858291-184858566	SK-N-SH_RA	brain:	n/a	n/a
14	EP300	chr1:184861125-184861646	GM12878	blood:	n/a	chr1:184861577-184861586 chr1:184861576-184861585
15	EP300	chr1:184858926-184859393	SK-N-SH_RA	brain:	n/a	n/a
16	EP300	chr1:184857274-184858306	SK-N-SH	brain:	n/a	n/a
17	EP300	chr1:184858328-184858385	K562	blood:	n/a	n/a
18	EP300	chr1:184861359-184861601	SK-N-SH_RA	brain:	n/a	chr1:184861577-184861586 chr1:184861576-184861585
19	EP300	chr1:184857542-184858620	SK-N-SH_RA	brain:	n/a	n/a
20	FOS	chr1:184857752-184858135	HUVEC	blood vessel:	n/a	chr1:184857904-184857915
21	FOS	chr1:184861404-184861733	MCF10A-Er-Src	breast:	n/a	chr1:184861577-184861585 chr1:184861578-184861585 chr1:184861577-184861586
22	FOS	chr1:184857760-184858079	MCF10A-Er-Src	breast:	n/a	chr1:184857904-184857915
23	FOS	chr1:184857748-184858092	MCF10A-Er-Src	breast:	n/a	chr1:184857904-184857915
24	FOS	chr1:184861407-184861687	MCF10A-Er-Src	breast:	n/a	chr1:184861577-184861585 chr1:184861578-184861585 chr1:184861577-184861586
25	FOS	chr1:184859576-184860093	Hela-S3	cervix:	n/a	chr1:184859642-184859654
26	FOS	chr1:184857760-184858082	MCF10A-Er-Src	breast:	n/a	chr1:184857904-184857915
27	FOS	chr1:184861384-184861733	MCF10A-Er-Src	breast:	n/a	chr1:184861577-184861585 chr1:184861578-184861585 chr1:184861577-184861586
28	FOS	chr1:184861411-184861635	MCF10A-Er-Src	breast:	n/a	chr1:184861577-184861585 chr1:184861578-184861585 chr1:184861577-184861586
29	FOS	chr1:184857620-184858104	Hela-S3	cervix:	n/a	chr1:184857904-184857915
30	FOS	chr1:184857737-184858190	MCF10A-Er-Src	breast:	n/a	chr1:184857904-184857915
31	FOS	chr1:184859193-184859301	MCF10A-Er-Src	breast:	n/a	n/a
32	FOSL1	chr1:184857538-184858198	HCT-116	colon:	n/a	n/a
33	FOSL1	chr1:184857691-184858192	HCT-116	colon:	n/a	n/a
34	FOSL2	chr1:184857381-184858163	SK-N-SH	brain:	n/a	n/a
35	FOSL2	chr1:184861216-184861808	SK-N-SH	brain:	n/a	chr1:184861577-184861585 chr1:184861578-184861585 chr1:184861577-184861586
36	FOXM1	chr1:184860958-184861670	GM12878	blood:	n/a	n/a
37	GATA1	chr1:184859277-184860859	PBDE	blood:	n/a	chr1:184860046-184860053 chr1:184860046-184860053 chr1:184860046-184860053 chr1:184860044-184860054 chr1:184860041-184860057 chr1:184860044-184860053 chr1:184859412-184859423 chr1:184860044-184860053
38	GATA2	chr1:184858307-184859046	SH-SY5Y	brain:	n/a	n/a
39	GATA3	chr1:184860059-184860258	SH-SY5Y	brain:	n/a	n/a
40	GATA3	chr1:184858959-184860203	SK-N-SH	brain:	n/a	chr1:184860046-184860053 chr1:184860046-184860053 chr1:184860046-184860053 chr1:184860044-184860054 chr1:184860041-184860057 chr1:184860044-184860053 chr1:184859412-184859423 chr1:184860044-184860053
41	GATA3	chr1:184857264-184858866	SK-N-SH	brain:	n/a	n/a
42	GATA3	chr1:184857334-184858898	SK-N-SH	brain:	n/a	n/a
43	GATA3	chr1:184858311-184858725	SH-SY5Y	brain:	n/a	n/a
44	GATA3	chr1:184858966-184860189	SK-N-SH	brain:	n/a	chr1:184860046-184860053 chr1:184860046-184860053 chr1:184860046-184860053 chr1:184860044-184860054 chr1:184860041-184860057 chr1:184860044-184860053 chr1:184859412-184859423 chr1:184860044-184860053
45	JUN	chr1:184858021-184858030	K562	blood:	n/a	n/a
46	JUN	chr1:184857692-184858073	Hela-S3	cervix:	n/a	n/a
47	JUND	chr1:184861461-184861702	HepG2	liver:	n/a	chr1:184861577-184861585 chr1:184861578-184861585 chr1:184861575-184861586 chr1:184861577-184861586
48	JUND	chr1:184861021-184861846	SK-N-SH	brain:	n/a	chr1:184861577-184861585 chr1:184861578-184861585 chr1:184861575-184861586 chr1:184861066-184861076 chr1:184861202-184861214 chr1:184861577-184861586
49	JUND	chr1:184857593-184858181	HCT-116	colon:	n/a	n/a
50	JUND	chr1:184857603-184858113	Hela-S3	cervix:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr1:184858456-184858506	GM12891	blood:	n/a
2	chr1:184858456-184858506	GM12891	blood:	n/a
3	chr1:184858456-184858506	AG04449	skin:	fetal
4	chr1:184858456-184858506	SK-N-SH	brain:	n/a
5	chr1:184858456-184858506	ovcar-3	ovarian:	n/a
6	chr1:184858456-184858506	HCF	heart:	n/a
7	chr1:184858456-184858506	HUVEC	blood vessel:	n/a
8	chr1:184858456-184858506	HIPEpiC	eye:	n/a
9	chr1:184858456-184858506	Hela-S3	cervix:	n/a
10	chr1:184858456-184858506	Caco-2	colon:	n/a
11	chr1:184858456-184858506	HCM	heart:	n/a
12	chr1:184858456-184858506	T-47D	breast:	n/a
13	chr1:184858456-184858506	LNCaP	prostate:	n/a
14	chr1:184858456-184858506	HRE	kidney:	n/a
15	chr1:184858456-184858506	AoSMC	blood vessel:	n/a
16	chr1:184858456-184858506	BE2_C	brain:	n/a
17	chr1:184858456-184858506	HEK293	kidney:	embryo
18	chr1:184858456-184858506	AG10803	skin:	n/a
19	chr1:184858456-184858506	SK-N-SH_RA	brain:	n/a
20	chr1:184858456-184858506	IMR90	lung:	fetal
21	chr1:184858456-184858506	PANC-1	pancreas:	n/a
22	chr1:184858456-184858506	NHBE	bronchial:	n/a
23	chr1:184858456-184858506	HepG2	liver:	n/a
24	chr1:184858456-184858506	AG04450	lung:	fetal
25	chr1:184858456-184858506	HRCEpiC	kidney:	n/a
26	chr1:184858456-184858506	GM19239	blood:	n/a
27	chr1:184858456-184858506	ECC-1	luminal epithelium:	n/a
28	chr1:184858456-184858506	HRPEpiC	eye:	n/a
29	chr1:184858456-184858506	HEEpiC	esophagus:	n/a
30	chr1:184858456-184858506	HCT-116	colon:	n/a
31	chr1:184858456-184858506	RPTEC	kidney:	n/a
32	chr1:184858456-184858506	CMK	blood:	n/a
33	chr1:184858456-184858506	PrEC	prostate:	n/a
34	chr1:184858456-184858506	A549	lung:	n/a
35	chr1:184858456-184858506	HMEC	breast:	n/a
36	chr1:184858456-184858506	ProgFib	skin:	n/a
37	chr1:184858456-184858506	NH-A	brain:	n/a
38	chr1:184858456-184858506	AG09309	skin:	n/a
39	chr1:184858456-184858506	U87	brain:	n/a
40	chr1:184858456-184858506	Jurkat	blood:	n/a
41	chr1:184858456-184858506	SAEC	small airway:	n/a
42	chr1:184858456-184858506	PFSK-1	brain:	n/a
43	chr1:184858456-184858506	MCF-7	breast:	n/a
44	chr1:184858456-184858506	GM12878	blood:	n/a
45	chr1:184858456-184858506	HCPEpiC	choroid plexus:	n/a
46	chr1:184858456-184858506	HPAEpiC	pulmonary alveolar:	n/a
47	chr1:184858456-184858506	GM06990	blood:	n/a
48	chr1:184858456-184858506	Hepatocyte	liver:	n/a
49	chr1:184858456-184858506	HNPCEpiC	eye:	n/a
50	chr1:184858456-184858506	NHDF-neo	bronchial:	n/a

Variant related genes	Relation type
FAM129A	TF binding region
FAM129A	CpG island

Extended variants
information (count: 117 )
Associated
traits (count: 85 )

Variant overlapped rSNPs/rCNVs (count:117 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs182710840	chr1:184857982-184857983	Weak transcription Enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs373403370	chr1:184858007-184858008	Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs562278022	chr1:184858121-184858122	Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs6662843	chr1:184858146-184858147	Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
5	rs74132068	chr1:184858183-184858184	Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs187938380	chr1:184858184-184858185	Weak transcription Enhancers Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs527446014	chr1:184858298-184858299	Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs79774645	chr1:184858347-184858348	Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs545051214	chr1:184858369-184858370	Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs548265801	chr1:184858380-184858381	Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs78543782	chr1:184858386-184858387	Weak transcription Enhancers Flanking Active TSS Strong transcription Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs557379963	chr1:184858422-184858423	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs146670506	chr1:184858456-184858457	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs536353334	chr1:184858586-184858587	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs555008924	chr1:184858592-184858593	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs573375523	chr1:184858693-184858694	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs540796112	chr1:184858727-184858728	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs558851948	chr1:184858763-184858764	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs373303572	chr1:184858770-184858771	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs148397008	chr1:184858785-184858786	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs543845814	chr1:184858986-184858987	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs562141892	chr1:184858990-184858991	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs574333455	chr1:184858999-184859000	Weak transcription Enhancers Transcr. at gene 5' and 3' Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs541575265	chr1:184859037-184859038	Weak transcription Enhancers Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs142740053	chr1:184859045-184859046	Weak transcription Enhancers Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs527520715	chr1:184859065-184859066	Weak transcription Enhancers Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs552382857	chr1:184859086-184859087	Weak transcription Enhancers Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs564411723	chr1:184859095-184859096	Weak transcription Enhancers Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs531631559	chr1:184859104-184859105	Weak transcription Enhancers Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs193052224	chr1:184859130-184859131	Weak transcription Enhancers Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs572395950	chr1:184859131-184859132	Weak transcription Enhancers Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs75783127	chr1:184859159-184859160	Weak transcription Enhancers Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs548416902	chr1:184859171-184859172	Weak transcription Enhancers Genic enhancers Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs372544063	chr1:184859203-184859204	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs377284162	chr1:184859204-184859205	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs184067662	chr1:184859209-184859210	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs368245982	chr1:184859214-184859215	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs187243425	chr1:184859218-184859219	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs558717825	chr1:184859227-184859228	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs12083767	chr1:184859240-184859241	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs201874357	chr1:184859258-184859259	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs140860927	chr1:184859311-184859312	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs372540876	chr1:184859312-184859313	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs556404470	chr1:184859317-184859318	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs574369653	chr1:184859318-184859319	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs377357410	chr1:184859388-184859389	Weak transcription Enhancers Strong transcription Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs199658865	chr1:184859400-184859401	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs370706856	chr1:184859487-184859488	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs192277423	chr1:184859493-184859494	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs572095774	chr1:184859569-184859570	Weak transcription Enhancers Flanking Active TSS Strong transcription Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:85)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Liposarcoma	21253554	CNVD
Burkitt''s lymphoma	18698080	CNVD
Melanoma	18172304	CNVD
Rett syndrome	21593744	CNVD
Cancer	20164919	CNVD
Medulloblastoma	21979893	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Bladder cancer	19088036	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	21858162	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Hepatocellular carcinoma	18803288	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Trisomy 5 syndrome	21098271	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Neuroblastoma	18923191	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Hepatocellular carcinoma	16750200	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21509527	CNVD
Glioblastoma multiforme	17369134	CNVD
Cancer	17440070	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Metanephric adenoma	20802469	CNVD
Renal cell carcinoma	18765545	CNVD
Nephroblastoma	17189400	CNVD
Melanoma	20688739	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21611746	CNVD
Myelofibrosis	22110671	CNVD
primary effusion lymphomas	17116491	CNVD
Breast cancer	17393978	CNVD
Barrett''s syndrome	19417022	CNVD

Chromatin state (count:227 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:184816800-184874200	Weak transcription	Esophagus	oesophagus
2	chr1:184831400-184874200	Weak transcription	Lung	lung
3	chr1:184837200-184858400	Weak transcription	K562	blood
4	chr1:184837200-184859800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
5	chr1:184837200-184869000	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
6	chr1:184838000-184859200	Weak transcription	Primary T cells fromperipheralblood	blood
7	chr1:184839800-184858600	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
8	chr1:184840000-184858200	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
9	chr1:184843000-184866800	Weak transcription	Primary hematopoietic stem cells	blood
10	chr1:184844200-184874200	Weak transcription	Adipose Nuclei	Adipose
11	chr1:184851600-184859600	Weak transcription	Duodenum Mucosa	Duodenum
12	chr1:184852000-184874200	Weak transcription	Spleen	Spleen
13	chr1:184852600-184859000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
14	chr1:184852600-184859600	Weak transcription	Gastric	stomach
15	chr1:184852800-184875800	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr1:184853000-184858600	Weak transcription	Primary T helper cells PMA-I stimulated	--
17	chr1:184853400-184859000	Weak transcription	Fetal Muscle Leg	muscle
18	chr1:184853800-184859800	Weak transcription	GM12878-XiMat	blood
19	chr1:184854000-184868600	Weak transcription	Fetal Stomach	stomach
20	chr1:184854200-184861200	Weak transcription	Fetal Muscle Trunk	muscle
21	chr1:184854600-184858000	Enhancers	Rectal Smooth Muscle	rectum
22	chr1:184854800-184859000	Weak transcription	Aorta	Aorta
23	chr1:184855000-184859600	Weak transcription	Primary T cells from cord blood	blood
24	chr1:184855200-184858400	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
25	chr1:184855400-184860000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
26	chr1:184855400-184860000	Enhancers	NHDF-Ad	bronchial
27	chr1:184855600-184858400	Weak transcription	Right Atrium	heart
28	chr1:184855600-184858600	Weak transcription	Right Ventricle	heart
29	chr1:184855600-184859200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
30	chr1:184855600-184868800	Strong transcription	Primary neutrophils fromperipheralblood	blood
31	chr1:184855600-184869200	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
32	chr1:184855800-184858400	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
33	chr1:184855800-184860000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
34	chr1:184855800-184868600	Strong transcription	Monocytes-CD14+_RO01746	blood
35	chr1:184856000-184859000	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
36	chr1:184856200-184859200	Enhancers	NHEK	skin
37	chr1:184856600-184859200	Strong transcription	Primary Natural Killer cells fromperipheralblood	blood
38	chr1:184856600-184859400	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
39	chr1:184856600-184860000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
40	chr1:184857000-184858000	Enhancers	Hela-S3	cervix
41	chr1:184857000-184858400	Strong transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
42	chr1:184857000-184858400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
43	chr1:184857000-184858800	Enhancers	Colon Smooth Muscle	Colon
44	chr1:184857000-184859200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
45	chr1:184857000-184859400	Enhancers	NH-A	brain
46	chr1:184857000-184860200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
47	chr1:184857000-184860400	Enhancers	Fetal Adrenal Gland	Adrenal Gland
48	chr1:184857200-184858000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
49	chr1:184857200-184858200	Enhancers	Osteobl	bone
50	chr1:184857200-184859200	Enhancers	Fetal Heart	heart

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links